课题基金 / 基金详情

A pilot pragmatic randomized controlled trial to evaluate the impact of improving access to drugs on type 2 diabetes care, outcomes and costs

A pilot pragmatic randomized controlled trial to evaluate the impact of improving access to drugs on type 2 diabetes care, outcomes and costs
一项实用性随机对照试点试验，旨在评估改善药物获取对 2 型糖尿病护理、结果和成本的影响
批准号：
370477
负责人：
Shah Baiju R
金额：
$28.58万
依托单位：
Institute for Clinical Evaluative Sciences-Toronto
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2017
资助国家：
加拿大
项目状态：
已结题
起止时间：
2017-09-01 至 2020-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=370477&lang=en
关键词：
Acces To Medications Diabetes Mellitus Health Equity Pilot And Feasibility Study Randomized Controlled Trial

项目摘要

项目成果

Shah Baiju R的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Canada is the only country with a universal health insurance system that does not provide coverage for prescription drugs to all residents. One-third of working-age Canadians have no insurance. Importantly, many of these uninsured patients already face ot
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Intergenerational impacts of diabetes among First Nations mothers and their children
Intergenerational impacts of diabetes among First Nations mothers and their children
Derivation of risk prediction models and a computer microsimulation model in type 2 diabetes to aid clinical decision making and health technology assessment.
Microalbuminuria and Retinopathy in Gestational Diabetes: The MARIGOLD Study
海外基金